Patents by Inventor Hidenori Matsusaka

Hidenori Matsusaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Paramyxovirus vector encoding angiogenesis gene and use thereof
    Patent number: 8211868
    Abstract: The present invention provides Paramyxovirus vectors encoding angiogenic genes and use of the same. The use of Paramyxovirus vectors enables effective transfer of angiogenic genes into individual tissues. FGF2 gene transferred into ischemic tissues in vivo induces expression of angiogenic genes without causing edema, and prevents necrosis due to ischemia. The vectors of the present invention are suitable for gene therapy targeted to ischemic tissues.
    Type: Grant
    Filed: March 16, 2011
    Date of Patent: July 3, 2012
    Assignee: DNAVEC Research Inc.
    Inventors: Yoshikazu Yonemitsu, Katsuo Sueishi, Masayuki Fukumura, Xiaogang Hou, Mamoru Hasegawa, Hidenori Matsusaka, Hiroyuki Tsutsui
  • PARAMYXOVIRUS VECTOR ENCODING ANGIOGENESIS GENE AND USE THEREOF
    Publication number: 20110212059
    Abstract: The present invention provides Paramyxovirus vectors encoding angiogenic genes and use of the same. The use of Paramyxovirus vectors enables effective transfer of angiogenic genes into individual tissues. FGF2 gene transferred into ischemic tissues in vivo induces expression of angiogenic genes without causing edema, and prevents necrosis due to ischemia. The vectors of the present invention are suitable for gene therapy targeted to ischemic tissues.
    Type: Application
    Filed: March 16, 2011
    Publication date: September 1, 2011
    Applicant: DNAVEC RESEARCH INC.
    Inventors: YOSHIKAZU YONEMITSU, KATSUO SUEISHI, MASAYUKI FUKUMURA, XIAOGANG HOU, MAMORU HASEGAWA, HIDENORI MATSUSAKA, HIROYUKI TSUTSUI
  • PARAMYXOVIRUS VECTOR ENCODING ANGIOGENESIS GENE AND USE THEREOF
    Publication number: 20100158867
    Abstract: The present invention provides Paramyxovirus vectors encoding angiogenic genes and use of the same. The use of Paramyxovirus vectors enables effective transfer of angiogenic genes into individual tissues. FGF2 gene transferred into ischemic tissues in vivo induces expression of angiogenic genes without causing edema, and prevents necrosis due to ischemia. The vectors of the present invention are suitable for gene therapy targeted to ischemic tissues.
    Type: Application
    Filed: September 30, 2009
    Publication date: June 24, 2010
    Applicant: DNAVEC RESEARCH INC.
    Inventors: Yoshikazu YONEMITSU, Katsuo Sueishi, Masayuki Fukumura, Xiaogang Hou, Mamoru Hasegawa, Hidenori Matsusaka, Hiroyuki Tsutsui
  • Paramyxovirus vector encoding angiogenesis gene and use thereof
    Publication number: 20040005296
    Abstract: The present invention provides Paramyxovirus vectors encoding angiogenic genes and use of the same. The use of Paramyxovirus vectors enables effective transfer of angiogenic genes into individual tissues. FGF2 gene transferred into ischemic tissues in vivo induces expression of angiogenic genes without causing edema, and prevents necrosis due to ischemia. The vectors of the present invention are suitable for gene therapy targeted to ischemic tissues.
    Type: Application
    Filed: May 23, 2003
    Publication date: January 8, 2004
    Inventors: Yoshikazu Yonemitsu, Katsuo Sueishi, Masayuki Fukumura, Xiaogang Hou, Mamoru Hasegawa, Hidenori Matsusaka, Hiroyuki Tsutsui